(Q48489815)

12 February 2018

title

Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial. (English)

1 reference

12 February 2018

1 reference

1 reference

1 reference

C Brown

11

0 references

author name string

M Brundage

1

1 reference

12 February 2018

M Gropp

2

1 reference

12 February 2018

F Mefti

3

1 reference

12 February 2018

K Mann

4

1 reference

12 February 2018

B Lund

5

1 reference

12 February 2018

V Gebski

6

1 reference

12 February 2018

G Wolfram

7

1 reference

12 February 2018

N Reed

8

1 reference

12 February 2018

S Pignata

9

1 reference

12 February 2018

A Ferrero

10

1 reference

12 February 2018

E Eisenhauer

12

1 reference

12 February 2018

E Pujade-Lauraine

13

1 reference

12 February 2018

publication date

30 January 2012

1 reference

12 February 2018

published in

Annals of Oncology

1 reference

12 February 2018

volume

23

1 reference

12 February 2018

issue

8

1 reference

12 February 2018

page(s)

2020-2027

1 reference

12 February 2018

Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Optimal chemotherapy treatment for women with recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

How can quality of life researchers make their work more useful to health workers and their patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

The clinical significance of quality of life assessments in oncology: a summary for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

The applications of PROs in clinical practice: what are they, do they work, and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR583

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDR583

1 reference

12 February 2018

1 reference

12 February 2018